Niagen Bioscience logo

Niagen Bioscience

NAGE | NASDAQ
Chart Builder DCF Calculator
$2.01
-$0.06 (-2.66%)
At close: Nov 16, 2026, 4:00 PM ET
$1.96
-$0.05 (-2.49%)
After-hours: Nov 16, 2026, 7:30 PM ET
-2.66%

Rating

Updated: Nov 16, 2026
46.5
Fundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #358/1021 (Top 35%)

Key Statistics

Market Data

Market Cap $159.19M
1D Range
1.97 2.07
52W Range
1.97 7.04

Valuation (TTM)

PE 16.75
PB 1.92
EV/EBITDA 13.45

Valuation (NTM)

Forward PE 34.33
Forward PEG -0.24
Price Target $10.00
Loading financial charts...

Profile

Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through Consumer products; Ingredients; and Pharmaceutical Segments. It prov...

Sector Healthcare
Industry Biotechnology
Employees 117
IPO Date Jun 24, 2015
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 4, 2026
EPS
-$0.01
Miss -49.93%
REV
$27.19M
Miss -10.02%
Next Earnings
Mar 3, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
3
Consensus
Buy
Price Target
$10.00
Upside
+397.51%
Buy (3)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.